Khuloud Al-Jamal is a Global STEM Professor at The Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong. She holds a concurrent appointment as a Chair of Drug Delivery & Nanomedicine, Institute of Pharmaceutical Science, King’s College London. She was The Head of Medicines Development, Institute of Pharmaceutical Science, King’s College London (2020-2024). She completed her PhD at the Centre for Drug Delivery Research and postdoctoral training at the Nanomedicine Lab, The School of Pharmacy, University of London (2000-2010). She undertook her pre-registration pharmacy training at University College London Hospitals. She started her academic career as an Assistant Professor at the Institute of Pharmaceutical Science, King’s College London in 2011 and was promoted to a Full Professor in 2016.

Her research focusses on developing nanomedicines to improve treatment of neurological diseases and cancer. She has published over 170 papers in ISI-refereed international journals receiving > 10,000 citations (H index = 55, i10-index 125, accessed 10/24) and was one of the World’s Top 2% researchers (2022-24) according to analysis conducted by Stanford University. She has filed 5 patent applications in UK and Europe. By 2024, She has trained >150 researchers since.

She is a recipient of the Royal Pharmaceutical Society of Great Britain Science Medal, becoming the third female to receive this award in a 43-year-history, Maplethorpe Fellowship for the promotion of pharmaceutical education and excellence in research (University of London), BBSRC New Investigator Award, the Controlled Release Society Nanomedicine and Nanoscale Delivery Young Investigator Award. She is a three-time winner of the Wellcome Trust Science Image Awards. She is an editorial board member for several journals such as Journal of Controlled Release, Biomaterials Science, Scientific Reports, MedBioMed and Journal of Drug Targeting. She is a Fellow of Royal Society of Chemistry and The Royal Pharmaceutical Society.